Charles River Microbial Solutions

Activities: Analysis

Trending Articles

  1. RCPE and InSilicoTrials to digitalise and accelerate the development of pharmaceutical manufacturing processes RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialise the XPS simulation software. Specifically developed for pharmaceutical applications, XPS allows...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Bringing CAR-T therapy within reach: how decentralised manufacturing will improve patient access By offering a lifeline to patients with otherwise untreatable conditions, CAR-T cell therapy has transformed cancer treatment. Yet, despite the breakthrough potential of these...
  3. Partnering for success: adaptable CDMO solutions for pharma, diagnostics, and biotech When it comes to liquid formulations and freeze-drying (lyophilisation) services, choosing a contract development and manufacturing organisation (CDMO) that prioritises...
  4. WHO pandemic agreement determined after three years of negotiation Through the deal, WHO will promote a unified, global response to future pandemics, ensuring that national health systems are equipped to control future outbreaks
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Strengthening drug substance development with robust RSM strategies Qixuan Lu, Vice President of Process Chemistry at BioDuro, explains why regulatory starting materials represent the foundation of pharmaceutical manufacturing

Upcoming event

Making Pharmaceuticals

29-30 April 2025 | Conference | Coventry, UK See all

Related Content

Research & Development

FairJourney Biologics acquires Charles River's US antibody discovery site

The antibody discovery and engineering site in South San Francisco, US will expand FairJourney's reach in the key North American market, while positioning the company in one of the world's largest biotech clusters
Research & Development

Charles River launches Rep/Cap plasmids to streamline adeno-associated viral vector manufacturing

Off-the-shelf Rep/Cap simplifies gene therapy supply chains with immediate availability
Research & Development

CELLphenomics and Charles River to expand 3D in vitro services for cancer therapy drug screening

CELLphenomics’ PD3D tumour model platform will expand Charles River’s portfolio of 3D in vitro testing services
Manufacturing

Multiply Labs' robotic pharmaceutical manufacturing project reaches proof-of-concept

The consortium which contains Multiply Labs, Thermo Fisher, Cytiva, UCSF and Charles River has reached proof-of-concept on a robotic and automated cell manufacturing system
Manufacturing

Charles River announces plasmid manufacturing collaboration with Fondazione Telethon

The two companies have agreed on a manufacturing collaboration that will produce pDNA, used to produce GMP lentivirus for ex vivo gene therapy
Manufacturing

Wheeler Bio welcomes Charles River's biologics lab at manufacturing facility

Deployed on-site at a client’s facility, Charles River helps implement a flexible biologics testing lab
Manufacturing

Charles River and Cure AP-4 collaborate on gene therapy

The company is set to perform HQ plasmid production in support of Phase I/II clinical trials for AP-4 Hereditary Spastic Paraplegia
Subscribe now